FIELD: medicine.
SUBSTANCE: after DNA is recovered from peripheral venous blood, a polymorphic version +250A/G of a lymphotoxin α (Ltα) gene is analysed. If the genotype +250GG Ltα is found, the favourable course of type 2 diabetes mellitus is predicted, and therapy with oral antihyperglycemic drugs is expected to have a positive effect.
EFFECT: invention provides deriving new assessment criteria of the clinical course and treatment efficacy in Russian individuals suffering from type 2 diabetes mellitus.
4 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RISK OF STAGE III HYPERTENSIVE DISEASE IN PATIENTS WITH HYPERTENSION WITH METABOLIC SYNDROME | 2014 |
|
RU2598745C2 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING TYPE TWO DIABETES MELLITUS IN PATIENTS WITH HYPERTENSIVE DISEASES | 2013 |
|
RU2521202C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA IN INDIVIDUALS DEPENDING ON PRESENCE/ABSENCE OF COMORBIDITY OF EYES | 2014 |
|
RU2597784C2 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA STAGE III-IV | 2014 |
|
RU2580308C1 |
| METHOD FOR PREDICTION RISK OF DEVELOPMENT OF DIABETIC ANGIOPATHY OF LOWER EXTREMITIES IN PATIENTS SUFFERING TYPE 2 DIABETES MELLITUS | 2012 |
|
RU2507520C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING HYPERTENSION IN INDIVIDUALS WHO HAVE FAMILY HISTORY | 2014 |
|
RU2580310C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING CHRONIC TRUE ECZEMA IN INDIVIDUALS DEPENDING ON AVAILABILITY OF FAMILY HISTORY | 2014 |
|
RU2585382C1 |
| METHOD FOR PREDICTION OF GLYCOSYLATED HAEMOGLOBIN IN PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE 2 | 2013 |
|
RU2533456C1 |
| METHOD FOR PREDICTION OF LENGTH OF ABSCESS FORMATION ACCOMPANYING ACUTE PANCREATITIS | 2012 |
|
RU2508549C1 |
| METHOD PREDICTION OF THERAPY EFFECIENCY FOR PATIENTS WITH TYPE 2 SUGAR DIABETES | 2015 |
|
RU2626670C2 |
